Skip to main content
Top
Published in: Journal of Neurology 4/2010

01-04-2010 | Original Communication

Social and clinical determinants of quality of life in Parkinson’s disease in Austria: a cohort study

Authors: Yaroslav Winter, Sonja von Campenhausen, Julia Gasser, Klaus Seppi, Jens-P. Reese, Karl-P. Pfeiffer, Kai Bötzel, Wolfgang H. Oertel, Richard Dodel, Werner Poewe

Published in: Journal of Neurology | Issue 4/2010

Login to get access

Abstract

Parkinson’s disease (PD) is associated with a reduction of health-related quality of life (HrQoL). Demographic and clinical determinants of HrQoL in PD have been previously investigated, but less is known about its social determinants. Data on HrQoL in Austrian patients with PD are not available. The objective of this cross-sectional survey was to evaluate HrQoL of Austrian patients with PD and to provide a comprehensive analysis of its social and clinical determinants. Outpatients (n = 100) with idiopathic PD were recruited in the Department of Neurology of the University Innsbruck. Clinical status was estimated using the Unified Parkison’s Disease Rating Scale (UPDRS). HrQoL was evaluated using a generic instrument, the EuroQol (EQ5D and EQ-VAS). Independent determinants of HrQoL were assessed in multivariate regression analysis. The proportion of PD patients with moderate or severe problems in at least one dimension of the EQ5D was significantly higher than in the general population (90.1 vs. 35.1%, P < 0.001). The mean EQ-VAS score in PD was lower than in the general population (48.9 ± 19.6 vs. 77.0 ± 20.8, P < 0.001). Social support (number of household members) was identified as an independent social determinant of HrQoL. Demographic and clinical determinants were age, depression, UPDRS and motor fluctuations. The analysis of determinants of HrQoL showed that a greater attention should be paid to social support and home care. Our data on HrQoL in PD should be considered in the development of new health care programs.
Literature
1.
go back to reference Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J (2005) Costs of disorders of the brain in Europe. Eur J Neurol 12(suppl 1):1–27CrossRefPubMed Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J (2005) Costs of disorders of the brain in Europe. Eur J Neurol 12(suppl 1):1–27CrossRefPubMed
2.
go back to reference Brazier J, Jones N, Kind P (1993) Testing the validity of the EuroQoL and comparing it with the SF-36 health survey questionnaire. Qual Life Res 2:169–180CrossRefPubMed Brazier J, Jones N, Kind P (1993) Testing the validity of the EuroQoL and comparing it with the SF-36 health survey questionnaire. Qual Life Res 2:169–180CrossRefPubMed
3.
go back to reference Carod-Artal FJ, Vargas AP, Martinez-Martin P (2007) Determinants of quality of life in Brazilian patients with Parkinson’s disease. Mov Disord 22:1408–1415CrossRefPubMed Carod-Artal FJ, Vargas AP, Martinez-Martin P (2007) Determinants of quality of life in Brazilian patients with Parkinson’s disease. Mov Disord 22:1408–1415CrossRefPubMed
4.
go back to reference Chapuis S, Ouchchane L, Metz O, Gerbaud L, Durif F (2005) Impact of the motor complications of Parkinson’s disease on the quality of life. Mov Disord 20:224–230CrossRefPubMed Chapuis S, Ouchchane L, Metz O, Gerbaud L, Durif F (2005) Impact of the motor complications of Parkinson’s disease on the quality of life. Mov Disord 20:224–230CrossRefPubMed
5.
go back to reference Ebrahim S (1995) Clinical and public health perspectives and applications of health-related quality of life measurement. Soc Sci Med 41:1383–1394CrossRefPubMed Ebrahim S (1995) Clinical and public health perspectives and applications of health-related quality of life measurement. Soc Sci Med 41:1383–1394CrossRefPubMed
6.
go back to reference Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198CrossRefPubMed Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198CrossRefPubMed
7.
go back to reference Forsaa EB, Larsen JP, Wentzel-Larsen T, Herlofson K, Alves G (2008) Predictors and course of health-related quality of life in Parkinson’s disease. Mov Disord 23:1420–1427CrossRefPubMed Forsaa EB, Larsen JP, Wentzel-Larsen T, Herlofson K, Alves G (2008) Predictors and course of health-related quality of life in Parkinson’s disease. Mov Disord 23:1420–1427CrossRefPubMed
8.
go back to reference Gibb WRG (1988) Accuracy in the clinical diagnosis of parkinsonian syndromes. Postgrad Med J 64:345–512CrossRefPubMed Gibb WRG (1988) Accuracy in the clinical diagnosis of parkinsonian syndromes. Postgrad Med J 64:345–512CrossRefPubMed
9.
go back to reference Gomez-Esteban JC, Zarranz JJ, Lezcano E, Tijero B, Luna A, Velasco F, Rouco I, Garamendi I (2007) Influence of motor symptoms upon the quality of life of patients with Parkinson’s disease. Eur Neurol 57:161–165CrossRefPubMed Gomez-Esteban JC, Zarranz JJ, Lezcano E, Tijero B, Luna A, Velasco F, Rouco I, Garamendi I (2007) Influence of motor symptoms upon the quality of life of patients with Parkinson’s disease. Eur Neurol 57:161–165CrossRefPubMed
10.
go back to reference Greiner W, Weijnen T, Nieuwenhuizen M, Oppe S, Badia X, Busschbach J, Buxton M, Dolan P, Kind P, Krabbe P, Ohinmaa A, Parkin D, Roset M, Sintonen H, Tsuchiya A, de Charro F (2003) A single European currency for EQ-5D health states. Results from a six-country study. Eur J Health Econ 4:222–231CrossRefPubMed Greiner W, Weijnen T, Nieuwenhuizen M, Oppe S, Badia X, Busschbach J, Buxton M, Dolan P, Kind P, Krabbe P, Ohinmaa A, Parkin D, Roset M, Sintonen H, Tsuchiya A, de Charro F (2003) A single European currency for EQ-5D health states. Results from a six-country study. Eur J Health Econ 4:222–231CrossRefPubMed
11.
go back to reference Harrell FE (2001) Regression modeling strategies. Springer, New York Harrell FE (2001) Regression modeling strategies. Springer, New York
12.
go back to reference Hobson P, Holden A, Meara J (1999) Measuring the impact of Parkinson’s disease with the Parkinson’s disease quality of life questionnaire. Age Ageing 28:341–346CrossRefPubMed Hobson P, Holden A, Meara J (1999) Measuring the impact of Parkinson’s disease with the Parkinson’s disease quality of life questionnaire. Age Ageing 28:341–346CrossRefPubMed
13.
go back to reference Karlsen KH, Larsen JP, Tandberg E, Maeland JG (1999) Influence of clinical and demographic variables on quality of life in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 66:431–435CrossRefPubMed Karlsen KH, Larsen JP, Tandberg E, Maeland JG (1999) Influence of clinical and demographic variables on quality of life in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 66:431–435CrossRefPubMed
14.
go back to reference Klepac N, Pikija S, Kraljic T, Relja M, Trkulja V, Juren S, Pavlicek I, Babic T (2007) Association of rural life setting and poorer quality of life in Parkinson’s disease patients: a cross-sectional study in Croatia. Eur J Neurol 14:194–198CrossRefPubMed Klepac N, Pikija S, Kraljic T, Relja M, Trkulja V, Juren S, Pavlicek I, Babic T (2007) Association of rural life setting and poorer quality of life in Parkinson’s disease patients: a cross-sectional study in Croatia. Eur J Neurol 14:194–198CrossRefPubMed
15.
go back to reference Konig HH, Bernert S, Angermeyer MC, Matschinger H, Martinez M, Vilagut G, Haro JM, de Girolamo G, de Graaf R, Kovess V, Alonso J (2009) Comparison of population health status in six European countries: results of a representative survey using the EQ-5D questionnaire. Med Care 47:255–261CrossRefPubMed Konig HH, Bernert S, Angermeyer MC, Matschinger H, Martinez M, Vilagut G, Haro JM, de Girolamo G, de Graaf R, Kovess V, Alonso J (2009) Comparison of population health status in six European countries: results of a representative survey using the EQ-5D questionnaire. Med Care 47:255–261CrossRefPubMed
16.
go back to reference Kuopio AM, Marttila RJ, Helenius H, Toivonen M, Rinne UK (2000) The quality of life in Parkinson’s disease. Mov Disord 15:216–223CrossRefPubMed Kuopio AM, Marttila RJ, Helenius H, Toivonen M, Rinne UK (2000) The quality of life in Parkinson’s disease. Mov Disord 15:216–223CrossRefPubMed
17.
go back to reference Lindgren P, von Campenhausen S, Spottke AE, Siebert U, Dodel R (2005) Cost of Parkinson’s disease in Europe. Eur J Neurol 12(suppl 1):68–73CrossRefPubMed Lindgren P, von Campenhausen S, Spottke AE, Siebert U, Dodel R (2005) Cost of Parkinson’s disease in Europe. Eur J Neurol 12(suppl 1):68–73CrossRefPubMed
18.
go back to reference Marras C, McDermott M, Rochon P, Tanner C, Naglie G, Lang A, Patrkinson Study Group DATATOP Investigators (2008) Predictors of deterioration in health-related quality of life in Parkinson’s disease: results from the DATATOP trial. Mov Disord 23:653–659CrossRefPubMed Marras C, McDermott M, Rochon P, Tanner C, Naglie G, Lang A, Patrkinson Study Group DATATOP Investigators (2008) Predictors of deterioration in health-related quality of life in Parkinson’s disease: results from the DATATOP trial. Mov Disord 23:653–659CrossRefPubMed
19.
go back to reference Martinez-Martin P, Gil-Nagel A, Gracia LM, Gomez JB, Martinez-Sarries J, Bermejo F (1994) Unified Parkinson’s disease rating scale characteristics and structure. The Cooperative Multicentric Group. Mov Disord 9:76–83CrossRefPubMed Martinez-Martin P, Gil-Nagel A, Gracia LM, Gomez JB, Martinez-Sarries J, Bermejo F (1994) Unified Parkinson’s disease rating scale characteristics and structure. The Cooperative Multicentric Group. Mov Disord 9:76–83CrossRefPubMed
20.
go back to reference Pechevis M, Clarke CE, Vieregge P, Khoshnood B, Deschaseaux-Voinet C, Berdeaux G, Ziegler M (2005) Effects of dyskinesias in Parkinson’s disease on quality of life and health-related costs: a prospective European study. Eur J Neurol 12:956–963CrossRefPubMed Pechevis M, Clarke CE, Vieregge P, Khoshnood B, Deschaseaux-Voinet C, Berdeaux G, Ziegler M (2005) Effects of dyskinesias in Parkinson’s disease on quality of life and health-related costs: a prospective European study. Eur J Neurol 12:956–963CrossRefPubMed
21.
go back to reference Peto V, Jenkinson C, Fitzpatrick R, Greenhall R (1995) The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Qual Life Res 4:241–248CrossRefPubMed Peto V, Jenkinson C, Fitzpatrick R, Greenhall R (1995) The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Qual Life Res 4:241–248CrossRefPubMed
22.
go back to reference Rahman S, Griffin HJ, Quinn NP, Jahanshahi M (2008) Quality of life in Parkinson’s disease: the relative importance of the symptoms. Mov Disord 23:1428–1434CrossRefPubMed Rahman S, Griffin HJ, Quinn NP, Jahanshahi M (2008) Quality of life in Parkinson’s disease: the relative importance of the symptoms. Mov Disord 23:1428–1434CrossRefPubMed
23.
go back to reference Reuther M, Spottke EA, Klotsche J, Riedel O, Peter H, Berger K, Athen O, Köhne-Volland R, Dodel RC (2007) Assessing health-related quality of life in patients with Parkinson’s disease in a prospective longitudinal study. Parkinsonism Relat Disord 13:108–114CrossRefPubMed Reuther M, Spottke EA, Klotsche J, Riedel O, Peter H, Berger K, Athen O, Köhne-Volland R, Dodel RC (2007) Assessing health-related quality of life in patients with Parkinson’s disease in a prospective longitudinal study. Parkinsonism Relat Disord 13:108–114CrossRefPubMed
24.
go back to reference Sautter J, Wick R, Adlkofer F, Baker MG (2003) Research in the European Union. Lancet Neurol 2:702–706CrossRefPubMed Sautter J, Wick R, Adlkofer F, Baker MG (2003) Research in the European Union. Lancet Neurol 2:702–706CrossRefPubMed
25.
go back to reference Scaravilli T, Gasparoli E, Rinaldi F, Polesello G, Bracco F (2003) Health-related quality of life and sleep disorders in Parkinson’s disease. Neurol Sci 24:209–210CrossRefPubMed Scaravilli T, Gasparoli E, Rinaldi F, Polesello G, Bracco F (2003) Health-related quality of life and sleep disorders in Parkinson’s disease. Neurol Sci 24:209–210CrossRefPubMed
26.
go back to reference Schrag A, Jahanshahi M, Quinn N (2000) How does Parkinson’s disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 15:1112–1118CrossRefPubMed Schrag A, Jahanshahi M, Quinn N (2000) How does Parkinson’s disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 15:1112–1118CrossRefPubMed
27.
go back to reference Schrag A, Jahanshahi M, Quinn N (2000) What contributes to quality of life in patients with Parkinson’s disease? J Neurol Neurosurg Psychiatry 69:308–312CrossRefPubMed Schrag A, Jahanshahi M, Quinn N (2000) What contributes to quality of life in patients with Parkinson’s disease? J Neurol Neurosurg Psychiatry 69:308–312CrossRefPubMed
28.
go back to reference Schrag A, Selai C, Jahanshani M, Quinn N (2000) The EQ-5D—a generic quality of life measure—is a useful instrument to measure quality of life in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 69:67–73CrossRefPubMed Schrag A, Selai C, Jahanshani M, Quinn N (2000) The EQ-5D—a generic quality of life measure—is a useful instrument to measure quality of life in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 69:67–73CrossRefPubMed
30.
go back to reference Group TheEuroQol (1990) EuroQol—a new facility for the measurement of health-related quality of life. Health Policy 16:199–208CrossRef Group TheEuroQol (1990) EuroQol—a new facility for the measurement of health-related quality of life. Health Policy 16:199–208CrossRef
31.
go back to reference The Global Parkinson’s Disease Survey (GPDS) Steering Committee (2002) Factors impacting on quality of life in Parkinson’s disease: results from an international survey. Mov Disord 17:60–67CrossRef The Global Parkinson’s Disease Survey (GPDS) Steering Committee (2002) Factors impacting on quality of life in Parkinson’s disease: results from an international survey. Mov Disord 17:60–67CrossRef
32.
go back to reference Visser M, van Rooden SM, Verbaan D, Marinus J, Stiggelbout AM, van Hilten JJ (2008) A comprehensive model of health-related quality of life in Parkinson’s disease. J Neurol 255:1580–1587CrossRefPubMed Visser M, van Rooden SM, Verbaan D, Marinus J, Stiggelbout AM, van Hilten JJ (2008) A comprehensive model of health-related quality of life in Parkinson’s disease. J Neurol 255:1580–1587CrossRefPubMed
33.
go back to reference Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483CrossRefPubMed Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483CrossRefPubMed
34.
go back to reference Welsh M, McDermott MP, Holloway RG, Plumb S, Pfeiffer R, Hubble J (2003) Development and testing of the Parkinson’s disease quality of life scale. Mov Disord 18:637–645CrossRefPubMed Welsh M, McDermott MP, Holloway RG, Plumb S, Pfeiffer R, Hubble J (2003) Development and testing of the Parkinson’s disease quality of life scale. Mov Disord 18:637–645CrossRefPubMed
35.
go back to reference Winter Y, von Campenhausen S, Brozova H, Skoupa J, Reese JP, Botzel K, Eggert K, Oertel WH, Dodel R, Ruzicka E (2009) Costs of illness of Parkinson’s disease in Eastern Europe: a Czech cohort study. Parkinsonism Relat Disord [Epub ahead of print] Winter Y, von Campenhausen S, Brozova H, Skoupa J, Reese JP, Botzel K, Eggert K, Oertel WH, Dodel R, Ruzicka E (2009) Costs of illness of Parkinson’s disease in Eastern Europe: a Czech cohort study. Parkinsonism Relat Disord [Epub ahead of print]
36.
go back to reference Winter Y, von Campenhausen S, Popov G, Reese JP, Klotsche J, Botzel K, Gusev E, Oertel WH, Dodel R, Guekht A (2009) Costs of Illness in a Russian Cohort of Patients with Parkinson’s Disease. PharmacoEconomics 27:571–584CrossRefPubMed Winter Y, von Campenhausen S, Popov G, Reese JP, Klotsche J, Botzel K, Gusev E, Oertel WH, Dodel R, Guekht A (2009) Costs of Illness in a Russian Cohort of Patients with Parkinson’s Disease. PharmacoEconomics 27:571–584CrossRefPubMed
37.
go back to reference World Health Organization (1993) The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. World Health Organization, Geneva World Health Organization (1993) The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. World Health Organization, Geneva
38.
go back to reference Zach M, Friedman A, Slawek J, Derejko M (2004) Quality of life in Polish patients with long-lasting Parkinson’s disease. Mov Disord 19:667–672CrossRefPubMed Zach M, Friedman A, Slawek J, Derejko M (2004) Quality of life in Polish patients with long-lasting Parkinson’s disease. Mov Disord 19:667–672CrossRefPubMed
Metadata
Title
Social and clinical determinants of quality of life in Parkinson’s disease in Austria: a cohort study
Authors
Yaroslav Winter
Sonja von Campenhausen
Julia Gasser
Klaus Seppi
Jens-P. Reese
Karl-P. Pfeiffer
Kai Bötzel
Wolfgang H. Oertel
Richard Dodel
Werner Poewe
Publication date
01-04-2010
Publisher
Springer-Verlag
Published in
Journal of Neurology / Issue 4/2010
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-009-5389-7

Other articles of this Issue 4/2010

Journal of Neurology 4/2010 Go to the issue